Cargando…
Case report: The activity of multi-kinase VEGF inhibitor, Pazopanib, in metastatic undifferentiated round cell sarcomas harboring EWSR1::CREM fusion: clinicopathological series of two cases and literature review
Soft tissue sarcomas harboring EWSR1::CREM fusion are rare and challenging to treat. Pazopanib, a multi-tyrosine kinase inhibitor, is FDA-approved for advanced soft tissue sarcomas, but predictive biomarkers for its efficacy remain unidentified. We conducted a study on > 240,000 neoplasms submitt...
Autores principales: | Campoverde, Leticia, Camacho, Felipe, Alessandrino, Francesco, Evans, Mark G., Elliot, Andrew, Rosenberg, Andrew, Trent, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565213/ https://www.ncbi.nlm.nih.gov/pubmed/37829338 http://dx.doi.org/10.3389/fonc.2023.1215003 |
Ejemplares similares
-
The oncogenic properties of the EWSR1::CREM fusion gene are associated with polyamine metabolism
por: Kaprio, Heidi, et al.
Publicado: (2023) -
Metastatic sporadic paraganglioma with EWSR1::CREM gene fusion: A unique molecular profile that expands the phenotypic diversity of the molecular landscape of the EWSR1::CREM gene fusion positive tumors
por: Javaid, Sehrish, et al.
Publicado: (2022) -
A Case of Buccal Clear Cell Carcinoma Caused by Rare Fusion Gene: EWSR1-CREM
por: Hoshino, Miyako, et al.
Publicado: (2021) -
Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma
por: Gouda, Mohamed A., et al.
Publicado: (2023) -
Clinicopathological and Genomic Features of Pediatric Intracranial Myxoid Mesenchymal Tumor with both of EWSR1-CREM Gene Fusion and MAP3K13 Mutation: A Case Report and Comparison with Adult Cases in the Literature
por: SASAKI, Minami, et al.
Publicado: (2022)